Skip to search formSkip to main contentSkip to account menu

FibroTest Score Measurement

Known as: FBRTST, FibroSure Score Measurement, FibroSURE Score 
A patented biomarker test (APHP, 2001) that measures liver pathology through the assessment of a six-parameter blood test (for alpha-2-macroglobulin… 
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Serum biomarkers for the evaluation of liver fibrosis: The need for better tests.
2016
2016
Utility and limitations of APRI and FIB 4 to predict staging in a cohort of nonselected outpatients with hepatitis
de Oliveira AC, et al. in this issue of Annals of Hepatology focus on the usefulness of AST-to-platelet ratio index (APRI) and… 
2014
2014
Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®).
2012
2012
Performances of Elasto-FibroTest(®), a combination between FibroTest(®) and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C.
2010
2010
The role of the non-invasive serum marker FibroTest–ActiTest in the prediction of histological stage of fibrosis and activity in children with naïve chronic hepatitis B infection
Abstract The aim of this study was to investigate whether the non-invasive serum marker FibroTest–ActiTest (FT–AT) reliably… 
2010
2010
Comparison of FibroTest-ActiTest with histopathology in demonstrating fibrosis and necroinflammatory activity in chronic hepatitis B and C.
AIMS FibroTest and ActiTest are noninvasive tests used in determining the level of fibrosis and the degree of necroinflammatory… 
2008
2008
Discordance between biochemical markers of liver activity and fibrosis (Actitest-Fibrotest) and liver biopsy in patients with chronic hepatitis C.
2007
2007
Non-invasive biomarkers FibroTest-ActiTest for replacing invasive liver biopsy: the need for change and action.
J Gastrointestin Liver Dis June 2007 Vol.16 No 2, 173-174 Address for correspondence: 1 Bedossa et al. found the best diagnostic… 
2005
2005
Dosage immunoturbidimétrique de l'alpha 2 macroglobuline (réactifs DakoCytomation) sur les automates Roche Diagnostics (Modular P, Cobas Intégra). Application au FibroTest-ActiTest®
BACKGROUND: Alpha2Macroglobulin (A2M) measure showed a revival since it was introduced into FibroTest-ActiTest-Fibro (FT-AT-Fibro… 
2004
2004
Biomarkers as non‐invasive assessment of hepatic fibrosis in chronic hepatitis C
Abstract  Liver biopsy has been considered as the gold standard for assessing the stage and the grade of chronic liver diseases… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)